You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Enabling extreme acceleration of graph analyticsin real-world applications
SBC: Accelogic, LLC Topic: SB152004Graph analytics have emerged as a prominent computational workload in the defense community, and are representative of fundamental kernels in national security applications. Processing speed is a fundamental requirement for these applications. Massively-parallel hardware architectures promise to increase the performance of graph analytics. However, significant improvements in software technologies ...
SBIR Phase I 2016 Department of DefenseDefense Advanced Research Projects Agency -
Development of a fiber optic high dynamic range magnetic field gradiometer operable in unshielded environments
SBC: TIPD LLC Topic: SB161005Proposed, is a low cost fiber optic high dynamic range magnetic field gradient measurement system for noninvasive, real-time monitoring of bio-magnetic activities with high spatiotemporal resolution in unshielded environment. Each gradient measurement system would consist of 1 scalar magnetometer, 1 each of horizontal and vertical gradiometers, and additional scalar magnetometers for background ma ...
SBIR Phase I 2016 Department of DefenseDefense Advanced Research Projects Agency -
A High Resolution Radiation Therapy Dosimetry system
SBC: DOSEIMAGING, LLC Topic: 399DESCRIPTION provided by applicant Modern radiation therapy treatment modalities such as intensity modulated radiation therapy are associated with complex dose distributions and sharp dose gradients Experimental dose validation using multidimensional high spatial resolution dosimeters is mandatory The product to be developed is a novel high resolution dosimetry system that combines reusabil ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Repurposing Pyrvinium as an Orphan Drug for Familial Adenomatous Polyposis
SBC: Stemsynergy Therapeutic Topic: 102DESCRIPTION provided by applicant The tumor suppressor Adenomatous Polyposis Coli APC directs degradation of catenin a central signaling protein in the WNT pathway Germline loss of function mutations in APC activate WNT signaling and underlie the inherited colorectal cancer predisposition syndrome Familial Adenomatous Polyposis FAP an orphan disease while somatic mutations lead to spo ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
PEGYLATED PEPTIDES LIGANDS TARGETING RADIATION-INDUCIBLE RECEPTORS ON CANCER
SBC: Medical Guidance Systems LLC Topic: 102DESCRIPTION provided by applicant The proposed research is the study of new paradigms in both the treatment of cancer and cancer drug development This platform technology will markedly expand the number of cancer specific surface receptors and antigens that can be targeted for drug delivery using peptide ligands The general principle of this new technology is that cancer cells respond to ioni ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development
SBC: NUVOX PHARMA, L.L.C. Topic: 394DESCRIPTION provided by applicant Pancreatic ductal adenocarcinoma PDAC is a deadly form of cancer and patient survival depends upon the stage of diagnosis While overall survival at diagnosis is only about months of patients with stage I disease survive years The best currently available diagnostic test which is routinely performed in patients at high risk for PDAC is endoscop ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Carbon Fiber Off-Loading Orthosis
SBC: Orthotic & Prosthetic Design, Inc. Topic: 200DESCRIPTION provided by applicant This proposed project will further develop a CFC off loading AFO designed to offload plantar pressures and optimize patient function through maximizing plantarflexor power production During Phase I we will determine the effects of varying design characteristics of CFC off loading AFOs We will refine and create new FEA models and algorithms that predict the ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Preclinical Testing of Tetrandrine against Noise-Induce Hearing Loss
SBC: GATEWAY BIOTECHNOLOGY, INC. Topic: RDESCRIPTION provided by applicant Noise is the most common occupational and environmental hazard thus it is not surprising that noise induced hearing loss NIHL is the second most common form of sensorineural hearing deficit second only to age related hearing loss Although therapeutics that target the free radical pathway have shown promise for reducing NIHL there are no medications approv ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Single-Molecule Analyte Detection by Molecular Motor-driven Nanodevices
SBC: Attometrics Topic: NIGMSDESCRIPTION provided by applicant There is an urgent need for a platform technology that can monitor changes in metabolite and protein biomarkers below current detection limits because in many cases the disease has progressed to an advanced state by the time the abundance of the biomarker has become measurable Our molecular motor powered nanodevice linked immunosorbent assay MONA LISA is ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a Non adjuvanted VLP Vaccine against Stealth H N Influenza
SBC: EPIVAX, INC. Topic: NIAIDDESCRIPTION provided by applicant The avian origin H N influenza virus that emerged in humans in China in presents a unique challenge to vaccine development because it is poorly immunogenic Neutralizing antibodies are not detected in acute phase infection Anti H antibody responses are significantly delayed and exhibit low avidity in comparison with antibodies generated following seas ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health